Global DNA Nanotechnology Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI04255779

Publication Date:

April 24, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global DNA Nanotechnology market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for DNA Nanotechnology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for DNA Nanotechnology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for DNA Nanotechnology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key DNA Nanotechnology players cover NuProbe, tilibit nanosystems, GATTAquant, INOVIO Pharmaceuticals, Novartis International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淒NA Nanotechnology Industry Forecast鈥� looks at past sales and reviews total world DNA Nanotechnology sales in 2024, providing a comprehensive analysis by region and market sector of projected DNA Nanotechnology sales for 2025 through 2031. With DNA Nanotechnology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Nanotechnology industry.
This Insight Report provides a comprehensive analysis of the global DNA Nanotechnology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on DNA Nanotechnology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global DNA Nanotechnology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Nanotechnology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Nanotechnology.
This report presents a comprehensive overview, market shares, and growth opportunities of DNA Nanotechnology market by product type, application, key players and key regions and countries.
Segmentation by Type:
Structural DNA Nanotechnology
Dynamic DNA Nanotechnology
Segmentation by Application:
Targeted Drug Delivery
Smart Pills
Nanolithography
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NuProbe
tilibit nanosystems
GATTAquant
INOVIO Pharmaceuticals
Novartis International

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global DNA Nanotechnology Market Size (2020-2031)
2.1.2 DNA Nanotechnology Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for DNA Nanotechnology by Country/Region (2020, 2024 & 2031)
2.2 DNA Nanotechnology Segment by Type
2.2.1 Structural DNA Nanotechnology
2.2.2 Dynamic DNA Nanotechnology
2.3 DNA Nanotechnology Market Size by Type
2.3.1 DNA Nanotechnology Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global DNA Nanotechnology Market Size Market Share by Type (2020-2025)
2.4 DNA Nanotechnology Segment by Application
2.4.1 Targeted Drug Delivery
2.4.2 Smart Pills
2.4.3 Nanolithography
2.4.4 Others
2.5 DNA Nanotechnology Market Size by Application
2.5.1 DNA Nanotechnology Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global DNA Nanotechnology Market Size Market Share by Application (2020-2025)
3 DNA Nanotechnology Market Size by Player
3.1 DNA Nanotechnology Market Size Market Share by Player
3.1.1 Global DNA Nanotechnology Revenue by Player (2020-2025)
3.1.2 Global DNA Nanotechnology Revenue Market Share by Player (2020-2025)
3.2 Global DNA Nanotechnology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DNA Nanotechnology by Region
4.1 DNA Nanotechnology Market Size by Region (2020-2025)
4.2 Global DNA Nanotechnology Annual Revenue by Country/Region (2020-2025)
4.3 Americas DNA Nanotechnology Market Size Growth (2020-2025)
4.4 APAC DNA Nanotechnology Market Size Growth (2020-2025)
4.5 Europe DNA Nanotechnology Market Size Growth (2020-2025)
4.6 Middle East & Africa DNA Nanotechnology Market Size Growth (2020-2025)
5 Americas
5.1 Americas DNA Nanotechnology Market Size by Country (2020-2025)
5.2 Americas DNA Nanotechnology Market Size by Type (2020-2025)
5.3 Americas DNA Nanotechnology Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC DNA Nanotechnology Market Size by Region (2020-2025)
6.2 APAC DNA Nanotechnology Market Size by Type (2020-2025)
6.3 APAC DNA Nanotechnology Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe DNA Nanotechnology Market Size by Country (2020-2025)
7.2 Europe DNA Nanotechnology Market Size by Type (2020-2025)
7.3 Europe DNA Nanotechnology Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa DNA Nanotechnology by Region (2020-2025)
8.2 Middle East & Africa DNA Nanotechnology Market Size by Type (2020-2025)
8.3 Middle East & Africa DNA Nanotechnology Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global DNA Nanotechnology Market Forecast
10.1 Global DNA Nanotechnology Forecast by Region (2026-2031)
10.1.1 Global DNA Nanotechnology Forecast by Region (2026-2031)
10.1.2 Americas DNA Nanotechnology Forecast
10.1.3 APAC DNA Nanotechnology Forecast
10.1.4 Europe DNA Nanotechnology Forecast
10.1.5 Middle East & Africa DNA Nanotechnology Forecast
10.2 Americas DNA Nanotechnology Forecast by Country (2026-2031)
10.2.1 United States Market DNA Nanotechnology Forecast
10.2.2 Canada Market DNA Nanotechnology Forecast
10.2.3 Mexico Market DNA Nanotechnology Forecast
10.2.4 Brazil Market DNA Nanotechnology Forecast
10.3 APAC DNA Nanotechnology Forecast by Region (2026-2031)
10.3.1 China DNA Nanotechnology Market Forecast
10.3.2 Japan Market DNA Nanotechnology Forecast
10.3.3 Korea Market DNA Nanotechnology Forecast
10.3.4 Southeast Asia Market DNA Nanotechnology Forecast
10.3.5 India Market DNA Nanotechnology Forecast
10.3.6 Australia Market DNA Nanotechnology Forecast
10.4 Europe DNA Nanotechnology Forecast by Country (2026-2031)
10.4.1 Germany Market DNA Nanotechnology Forecast
10.4.2 France Market DNA Nanotechnology Forecast
10.4.3 UK Market DNA Nanotechnology Forecast
10.4.4 Italy Market DNA Nanotechnology Forecast
10.4.5 Russia Market DNA Nanotechnology Forecast
10.5 Middle East & Africa DNA Nanotechnology Forecast by Region (2026-2031)
10.5.1 Egypt Market DNA Nanotechnology Forecast
10.5.2 South Africa Market DNA Nanotechnology Forecast
10.5.3 Israel Market DNA Nanotechnology Forecast
10.5.4 Turkey Market DNA Nanotechnology Forecast
10.6 Global DNA Nanotechnology Forecast by Type (2026-2031)
10.7 Global DNA Nanotechnology Forecast by Application (2026-2031)
10.7.1 GCC Countries Market DNA Nanotechnology Forecast
11 Key Players Analysis
11.1 NuProbe
11.1.1 NuProbe Company Information
11.1.2 NuProbe DNA Nanotechnology Product Offered
11.1.3 NuProbe DNA Nanotechnology Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 NuProbe Main Business Overview
11.1.5 NuProbe Latest Developments
11.2 tilibit nanosystems
11.2.1 tilibit nanosystems Company Information
11.2.2 tilibit nanosystems DNA Nanotechnology Product Offered
11.2.3 tilibit nanosystems DNA Nanotechnology Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 tilibit nanosystems Main Business Overview
11.2.5 tilibit nanosystems Latest Developments
11.3 GATTAquant
11.3.1 GATTAquant Company Information
11.3.2 GATTAquant DNA Nanotechnology Product Offered
11.3.3 GATTAquant DNA Nanotechnology Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GATTAquant Main Business Overview
11.3.5 GATTAquant Latest Developments
11.4 INOVIO Pharmaceuticals
11.4.1 INOVIO Pharmaceuticals Company Information
11.4.2 INOVIO Pharmaceuticals DNA Nanotechnology Product Offered
11.4.3 INOVIO Pharmaceuticals DNA Nanotechnology Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 INOVIO Pharmaceuticals Main Business Overview
11.4.5 INOVIO Pharmaceuticals Latest Developments
11.5 Novartis International
11.5.1 Novartis International Company Information
11.5.2 Novartis International DNA Nanotechnology Product Offered
11.5.3 Novartis International DNA Nanotechnology Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Novartis International Main Business Overview
11.5.5 Novartis International Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂